TrialThe Journal of infectious diseases2010

AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein.

Robert T Schooley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.